ArticleNPJ digital medicine2025
An end-to-end deep learning pipeline for hematoma expansion prediction in spontaneous intracerebral hemorrhage based on non-contrast computed tomography.
Article in NPJ digital medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Hematoma expansion (HE) is a critical therapeutic target in spontaneous intracerebral hemorrhage (sICH), yet its reliable early identification remains challenging. We developed an automated pipeline for HE prediction using non-contrast computed tomography from 2020 patients across five centers. The modular framework comprised automated segmentation, synthetic data augmentation, and Vision Transformer (ViT)-based classification. High-quality hematoma masks were generated by the full-scale U-Mamba model, identified as the optimal architecture through comprehensive benchmarking. Two augmented training sets were constructed using synthetic HE images from the Diffusion-UKAN model: UKAN-Balanced (HE: NHE = 1:1) and UKAN-Semibalanced (HE: NHE = 1:2). The ViT-1:2 classifier, trained on the UKAN-Semibalanced dataset, achieved a training set AUC of 0.815 and demonstrated robust cross-institutional generalization with external validation AUCs of 0.793 and 0.781 on two independent datasets. These findings suggest that the proposed modular approach provides a promising front-line tool for rapid HE risk stratification in acute care settings, with potentially improving clinical decision-making in sICH management.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.